A Study to Evaluate the Safety of Recombinant Herpes Zoster Vaccine for Healthy Individuals

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Herpes Zoster (HZ)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Hubei Provincial Center for Disease Control and Prevention, Wuhan, Hubei, China

    Contact: Study coordinator (Yeqing Tong) · 63382251@qq.com · 027-87652057
Study leads
  • Yeqing Tong

    Principal Investigator

    Hubei Provincial Center for Disease Control and Prevention